Delivery Order SPE2DB22D2009-SPE2DB25FL6MB

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,845.56 firm fixed-price delivery order is for the provision of "MUCUS RELIEF ER 600 MG TABLET 500S" and has an ultimate completion date of December 5, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical division,...
This federal contract award, valued at $7,065.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MUCUS RELIEF ER 600 MG TABLET 500S, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of November 18, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of MUCUS RELIEF ER 600 MG TABLET 500S. The $1,243.95 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,187.64, is a delivery order for the supply of "MUCUS RLF DM ER 600-30 MG TAB 20S", a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 14, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $3,210.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for MUCUS RELIEF ER 600 MG TABLET 500S, with a firm fixed price and an ultimate completion date of December 16, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,053.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566429897 MUCUS RELIEF ER 600 MG TABLET 500S, with a completion date of November 15, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside requirements, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $3,860.98 and covers the delivery of MUCUS RELIEF ER 600 MG TABLET 500S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award, valued at $1,962.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for MUCUS RELIEF ER 600 MG TABLET 500S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,200.12, is a delivery order for the supply of "MUCUS RELIEF ER 600 MG TABLET 500S". The contract has an ultimate completion date of March 4, 2025 and is a firm fixed-price arrangement. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The federal contract award SPE2DB20D3103|SPE2DB25FM9H6, valued at $1,088.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of "MUCUS RELIEF ER 600 MG TABLET 500S" and has a firm fixed price pricing type with an ultimate completion date of March 5, 2025. This contract award is part of Amerisourcebergen's larger Indefinite Delivery...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL6MB
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MUCUS RELIEF ER 600 MG TABLET 500S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,142.68 and a period of performance through November 18, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award falls under that larger IDC, which encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 1:57 PM